Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Arlington › NPI 1073566246
Hospital

Public Hospital Dist No 1 Skagit

Public Hospital Dist No 1 Skagit was paid $17.23M by Medicaid between Jan 2018 and Dec 2024, across 235 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 13% of everything it billed.

33Billing provider infoPUBLIC HOSPITAL DIST NO 1 SKAGIT
ARLINGTON, WA 98223
33aNPI1073566246assigned 05/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.23M
24GClaims538,474
24DCodes billed235
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#27 of 49
Median peer was paid$20.06M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201868,967$2.55M
201976,189$2.60M
202072,623$2.19M
202181,654$2.49M
202283,800$2.29M
202390,377$2.78M
2024incomplete64,864$2.32M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 13% 11,547 9,939 $2.24M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 17,717 16,624 $2.20M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 13% 19,026 18,084 $2.16M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 12% 14,629 13,562 $2.11M
74177 Computed tomography, abdomen and pelvis; with contrast material 7.2% 4,732 4,546 $1.24M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.0% 5,649 5,439 $515K
70450 Computed tomography, head or brain; without contrast material 2.7% 3,521 3,340 $473K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.7% 1,995 1,923 $472K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 2.3% 4,051 1,732 $398K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.6% 4,296 3,797 $283K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.6% 2,641 2,535 $276K
80053 Comprehensive metabolic panel 1.3% 29,798 26,119 $221K
223 more codes
G0378 Hospital observation service, per hour 1.3% 1,495 $217K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.3% 13,254 $217K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.1% 1,590 $198K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 941 $170K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 895 $164K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,971 $164K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,119 $163K
71275 Computed tomographic angiography, chest, with contrast material <1% 839 $162K
96375 Therapeutic injection; each additional sequential IV push <1% 11,289 $152K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,944 $133K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 30,040 $129K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,850 $108K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,207 $104K
76830 Ultrasound, transvaginal <1% 1,466 $103K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 268 $90K
36415 Collection of venous blood by venipuncture <1% 36,842 $87K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,310 $83K
84484 <1% 8,107 $78K
71046 Radiologic examination, chest; 2 views <1% 2,790 $78K
71045 Radiologic examination, chest; single view <1% 6,181 $73K
76801 <1% 1,160 $71K
96376 <1% 5,045 $70K
93971 <1% 768 $65K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 1,377 $61K
84443 Thyroid stimulating hormone (TSH) <1% 5,924 $57K
72125 Computed tomography, cervical spine; without contrast material <1% 695 $54K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,089 $50K
83690 <1% 9,996 $44K
J7030 Infusion, normal saline solution , 1000 cc <1% 15,212 $43K
84145 <1% 1,926 $41K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 291 $40K
83880 <1% 3,101 $40K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,056 $39K
87040 <1% 3,299 $38K
83605 <1% 4,467 $37K
85379 <1% 2,885 $35K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,009 $33K
73630 <1% 1,400 $33K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,668 $33K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,760 $33K
81001 <1% 11,968 $31K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 6,001 $30K
72100 <1% 877 $27K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,710 $27K
73610 <1% 1,121 $26K
81025 <1% 6,367 $25K
73030 <1% 982 $25K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,213 $24K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,280 $22K
77063 Screening digital breast tomosynthesis, bilateral <1% 892 $22K
83735 <1% 7,189 $22K
87077 <1% 3,906 $21K
73130 <1% 771 $21K
83036 Hemoglobin; glycosylated (A1C) <1% 2,060 $21K
90715 <1% 1,018 $20K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,185 $19K
87181 <1% 3,511 $19K
80048 Basic metabolic panel (calcium, ionized) <1% 2,663 $17K
74018 <1% 824 $17K
12001 <1% 112 $16K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,321 $16K
84439 <1% 1,565 $15K
80061 Lipid panel <1% 1,794 $15K
85027 <1% 3,786 $15K
84702 <1% 1,978 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,103 $15K
10060 <1% 95 $15K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 313 $15K
J1170 Injection, hydromorphone, up to 4 mg <1% 6,032 $14K
87070 <1% 2,284 $14K
71250 <1% 174 $14K
73562 <1% 621 $13K
93970 <1% 140 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 310 $12K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,649 $12K
82962 <1% 5,285 $11K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 111 $11K
87081 <1% 1,276 $11K
81000 <1% 2,882 $10K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,075 $10K
85610 <1% 4,694 $10K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 155 $10K
36000 <1% 1,841 $10K
73110 <1% 442 $9K
86140 <1% 1,560 $9K
87075 <1% 1,531 $9K
86900 <1% 1,901 $9K
87581 <1% 155 $9K
J2704 Injection, propofol, 10 mg <1% 3,418 $8K
86850 <1% 1,422 $8K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,378 $8K
76642 <1% 153 $7K
87205 <1% 2,305 $7K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 779 $7K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,944 $7K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,169 $6K
70496 <1% 27 $6K
81003 <1% 3,608 $6K
86901 <1% 1,911 $6K
J7050 Infusion, normal saline solution, 250 cc <1% 2,968 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,442 $6K
84703 <1% 1,290 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,061 $5K
85732 <1% 1,523 $5K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 173 $5K
J2060 Injection, lorazepam, 2 mg <1% 2,522 $5K
94060 <1% 103 $5K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 450 $5K
11045 <1% 49 $4K
73564 <1% 120 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,360 $4K
82150 <1% 1,140 $4K
82550 <1% 1,187 $4K
86803 <1% 420 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,683 $4K
82553 <1% 365 $4K
82077 <1% 2,300 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 51 $4K
85007 <1% 1,270 $4K
86592 <1% 622 $3K
87486 <1% 155 $3K
C2627 Catheter, suprapubic/cystoscopic <1% 297 $3K
70498 <1% 26 $3K
87088 <1% 643 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,959 $3K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 307 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 224 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 105 $3K
87507 <1% 55 $3K
70486 <1% 36 $2K
94729 <1% 103 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,083 $2K
J3490 Unclassified drugs <1% 1,182 $2K
93975 <1% 31 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 933 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 219 $2K
94726 <1% 75 $2K
12002 <1% 12 $2K
85651 <1% 587 $2K
82728 <1% 126 $2K
85652 <1% 754 $2K
72040 <1% 59 $2K
73502 <1% 77 $1K
59025 Fetal non-stress test <1% 18 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 86 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 92 $1K
87340 <1% 216 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 102 $1K
83550 <1% 131 $1K
87184 <1% 298 $1K
80143 <1% 415 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 148 $1K
94799 <1% 339 $1K
85018 <1% 586 $1K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 12 $1K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 343 $925.99
87807 <1% 117 $893.63
81002 <1% 420 $891.32
76870 <1% 13 $885.86
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 14 $868.83
83540 <1% 134 $864.47
76536 <1% 13 $797.90
80179 <1% 385 $787.77
87210 <1% 193 $781.49
J3360 Injection, diazepam, up to 5 mg <1% 107 $758.28
86787 <1% 80 $742.30
82075 <1% 180 $706.44
92587 <1% 12 $687.79
76942 <1% 12 $676.72
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 621 $668.36
96367 <1% 61 $668.31
71271 <1% 17 $636.47
87147 <1% 116 $605.54
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 98 $590.63
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,010 $500.04
73140 <1% 36 $490.30
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 977 $474.28
77065 Tomosynthesis, mammo <1% 12 $438.25
88304 <1% 46 $430.19
77066 Tomosynthesis, mammo <1% 14 $427.74
73590 <1% 27 $382.65
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,584 $373.37
82805 <1% 75 $362.93
86762 <1% 57 $357.77
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,387 $356.43
85014 <1% 83 $339.37
82375 <1% 92 $330.40
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 120 $298.96
J3475 Injection, magnesium sulfate, per 500 mg <1% 103 $275.82
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 137 $240.76
73080 <1% 14 $239.64
82570 <1% 55 $201.57
J1171 Injection, hydromorphone, 0.1 mg <1% 105 $194.12
J0780 Injection, prochlorperazine, up to 10 mg <1% 120 $173.85
84100 <1% 42 $138.08
J3370 Injection, vancomycin hcl, 500 mg <1% 36 $130.09
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,010 $127.27
82607 <1% 12 $116.64
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 30 $114.24
83615 <1% 68 $106.43
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 64 $104.94
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 869 $79.55
84436 <1% 17 $64.96
83050 <1% 36 $62.46
81015 <1% 26 $55.02
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 789 $52.60
J1644 Injection, heparin sodium, per 1000 units <1% 199 $49.23
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 26 $49.00
J1815 Injection, insulin, per 5 units <1% 95 $38.66
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 14 $30.04
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 12 $25.64
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 14 $21.44
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 28 $20.67
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 55 $20.29
J1790 Injection, droperidol, up to 5 mg <1% 15 $20.05
J8540 Dexamethasone, oral, 0.25 mg <1% 152 $15.18
J1630 Injection, haloperidol, up to 5 mg <1% 32 $14.38
0353U <1% 165 $4.31
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 20 $0.02
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 977 $0.00
A9270 Non-covered item or service 0% 1,047 $0.00
0352U 0% 26 $0.00
G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening 0% 53 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBARNETT, JOLA (ASSISTANT ADMINISTRATOR- BUSINESS S)